| CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases S Gómez-Melero, Caballero-Villarraso Antibodies 12, 30, 2023 | 17 | 2023 |
| Amino terminal recognition by a CCR6 chemokine receptor antibody blocks CCL20 signaling and IL-17 expression via β-arrestin S Gómez-Melero, FI García-Maceira, T García-Maceira, V Luna-Guerrero, ... BMC biotechnology 21, 1-15, 2021 | 6 | 2021 |
| Development of a high-throughput calcium mobilization assay for CCR6 receptor coupled to hydrolase activity readout S Gómez-Melero, FI García-Maceira, T García-Maceira, V Luna-Guerrero, ... Biomedicines 10 (2), 422, 2022 | 4 | 2022 |
| Impact of Cognitive Impairment on Quality of Life in Multiple Sclerosis Patients—A Comprehensive Review S Gómez-Melero, J Caballero-Villarraso, BM Escribano, ... Journal of Clinical Medicine 13 (11), 3321, 2024 | 3 | 2024 |
| Preclinical Evidence for the Use of Oral Mesenchymal Stem Cell-Derived Extracellular Vesicles in Bone Regenerative Therapy: A Systematic Review A Olaechea, K Benabdellah, A Vergara-Buenaventura, S Gómez-Melero, ... Stem Cells Translational Medicine 12 (12), 791-800, 2023 | 2 | 2023 |
| One-Year Impact of Occupational Exposure to Polycyclic Aromatic Hydrocarbons on Sperm Quality MV Peña-García, MJ Moyano-Gallego, S Gómez-Melero, R Molero-Payán, ... Antioxidants 13 (10), 1181, 2024 | | 2024 |
| MIND Diet Impact on Multiple Sclerosis Patients: Biochemical Changes after Nutritional Intervention A Navarrete-Pérez, S Gómez-Melero, BM Escribano, A Galvao-Carmona, ... International Journal of Molecular Sciences 25 (18), 10009, 2024 | | 2024 |
| Desarrollo de anticuerpos terapéuticos contra el receptor CCR6 humano S Gómez-Melero Universidad de Córdoba, UCOPress, 2022 | | 2022 |
| Acetylated chitosan surfaces for the development of a highly sensitive ELISA EPR Tania García-Maceira, Ana B. Aragón Gómez, Verónica Luna-Guerrero ... BMC Biotechnology 19 (78), 2019 | | 2019 |
